TITLE

New generic launches buoy growth

PUB. DATE
September 2006
SOURCE
Drug Store News;9/25/2006, Vol. 28 Issue 12, p26
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports on the expiration of patent licenses of major brand-name drugs which experts say the beginning of patent expirations of branded drugs spanning for 5 years in the U.S. Three of the major brand name drugs who lost its patent protection included Zocor manufactured by Merck Pharmaceuticals, Pravachol from Bristol-Myers Squibb Co. and Zoloft from Pfizer Inc. The trend gave way for the approval of patent license of big generic drugs, thus increasing market share and sales.
ACCESSION #
22633589

 

Related Articles

  • US Pharma Majors Face Earnings Slowdown. Van Arnum, Patricia // Chemical Market Reporter;3/21/2005, Vol. 267 Issue 12, p4 

    The article reports that Bin Li, vice president and U.S. pharmaceutical analyst with Merrill Lynch said recently that they expect an average of low single-digit earnings per share growth through 2007 among the U.S. pharmaceutical majors Bristol-Myers Squibb Co., Pfizer Inc., Merck & Co. Inc.,...

  • 3Q sales of locally produced drugs reach $20.1 billion. Martinez, Marialba // Caribbean Business;11/20/2003, Vol. 31 Issue 46, p16 

    Reports on the increased sales of drugs produced in Puerto Rico during the third quarter of 2003. Total value of sales; Top sales performances by Pfizer Inc., Merck & Co., Bristol-Myers Squibb, Abbott Laboratories, Amgen, Eli-Lilly & Co., Schering-Plough Corp. and Wyeth; Strong results of the...

  • Pharmaceuticals in Canada.  // Pharmaceuticals Industry Profile: Canada;November 2004, p1 

    Presents a profile of the Pharmaceuticals industry in Canada. Background on Datamonitor, a business information company specializing in industry analysis; Executive summary of the industry; Market overview; Market value; Market segmentation; Competitive landscape; Leading companies in the...

  • Pharmaceuticals in France.  // Pharmaceuticals Industry Profile: France;January 2003, pN.PAG 

    Presents a profile of the Pharmaceuticals industry in France. Background on Datamonitor, a business information company specializing in industry analysis; Executive summary of the industry; Market overview; Market value; Market segmentation; Competitive landscape; Leading companies in the...

  • Reefer sanity. Wadman, Meredith // Fortune;11/24/2003, Vol. 148 Issue 11, p58 

    Reports that pharmaceutical companies are developing drugs that will hinder brain signals that trigger hunger. Focus on the cannabinoid receptor; Companies doing research into this area including Merck & Co. Inc., Pfizer Inc., and Bristol-Myers Squibb Co.

  • Pharmaceutical Companies.  // njbiz;7/4/2005, Vol. 18 Issue 27, p136 

    Presents the top pharmaceutical companies based on the number of employees in New Jersey from 2005 to 2006. Johnson & Johnson; Merck; Bristol-Myers Squibb; Pfizer;

  • Bristol-Myers Agrees to Buy Amylin.  // MondayMorning;7/9/2012, Vol. 20 Issue 27, p1 

    The article reports on the acquisition of Amylin Pharmaceuticals Inc. by Bristol-Myers Squibb Co. for $5.3 billion in 2012. It says that the deal is the second largest merger agreement declared in the said year for Bristol. Meanwhile, it mentions AstraZeneca PLC, Pfizer Inc., and Merck & Co....

  • Pipeline.  // Medical Marketing & Media;Oct2014, Vol. 49 Issue 10, p14 

    This section offers news briefs relevant to the pharmaceutical industry as of October 2014 which include Merck and Co. Inc.'s phase 3 trial of its osteoporosis drug odanacatib and the approval of Bristol-Myers Squibb and Pfizer Inc.'s Eliquis for the treatment of pulmonary embolism.

  • Decades of Change for the Top Pharmaceutical Companies. Van Arnum, Patricia // Pharmaceutical Technology;Jul2012, Vol. 36 Issue 7, p54 

    The article focuses on the change of the top pharmaceutical companies in 2012, which center on drug prescription. It says that Merck & Co. was ranked as the number one company in the sale of drugs prescription, followed by Bristol-Myers Squibb Co. due to the merger between Bristol-Myers and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics